Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 343(7):481–492

Article  CAS  PubMed  Google Scholar 

Huang W, Bai L, Tang H (2023) Epstein-Barr virus infection: the micro and macro worlds. Virol J 20(1):220

Article  PubMed  PubMed Central  Google Scholar 

Fugl A, Andersen CL (2019) Epstein-Barr virus and its association with the disease - a review of relevance to general practice. BMC Fam Pract 20(1):62

Article  PubMed  PubMed Central  Google Scholar 

Axelrod P, Finestone AJ (1990) Infectious Mononucleosis in older adults. Am Fam Physician 42(6):1599–1606

CAS  PubMed  Google Scholar 

Glynn FJ, Mackle T, Kinsella J (2007) Upper airway obstruction in infectious Mononucleosis. Eur J Emerg Med 14(1):41–42

Article  PubMed  Google Scholar 

Yamaguchi M, Kwong YL, Kim WS et al (2011) Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study. J Clin Oncol 29(33):4410–4416

Article  CAS  PubMed  Google Scholar 

Ghione P, Qi S, Imber BS et al (2020) Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population. Leuk Lymphoma 61(14):3331–3341

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang Y, Zhu Y, Cao JZ et al (2015) Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study. Blood 126(12):1424–1432 quiz 1517

Article  CAS  PubMed  Google Scholar 

van Doesum JA, Niezink AGH, Huls GA, Beijert M, Diepstra A, van Meerten T (2021) Extranodal Natural Killer/T-cell lymphoma, nasal type: diagnosis and treatment. Hemasphere 5(2):e523

Article  PubMed  PubMed Central  Google Scholar 

Styczynski J, van der Velden W, Fox CP et al (2016) Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines. Haematologica.;101(7):803–811

El-Mallawany NK, Curry CV, Allen CE (2022) Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes. Br J Haematol 196(1):31–44

Article  PubMed  Google Scholar 

Henter JI, Horne A, Arico M et al (2007) HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2):124–131

Article  PubMed  Google Scholar 

Shuyan Yao LH, Dina Suolitiken H, Zou Y, Zhu Y, Wang (2024) Transplantation in adult patients with Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis: yes or no? Blood 144(20):2107–2120

Article  PubMed  Google Scholar 

iTo YKH, Maeda Y et al (2012) Pretreatment EBV-DNA copy is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type. Clin Cancer Res 18:4183–4190

Article  CAS  PubMed  Google Scholar 

Wang IWH, Wang JH et al (2015) Post-treatment plasma EBV-DNA positivity predicts early relapse and poor prognosis for patients with extranodal NK/T cell lymphoma in the era of asparaginase. Oncotarget 6:30317–30326

Article  PubMed  PubMed Central  Google Scholar 

Kim SJ, Yoon DH, Jaccard A et al (2016) A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol 17(3):389–400

Article  CAS  PubMed  Google Scholar 

Papalexandri A, Gavriilaki E, Vardi A et al (2023) Pre-emptive use of Rituximab in Epstein-Barr Virus Reactivation: incidence, predictive factors, monitoring, and outcomes. Int J Mol Sci.;24(22)

Styczynski J, Gil L, Tridello G et al (2013) Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the infectious diseases Working Party of the European Group for Blood and marrow transplantation. Clin Infect Dis 57(6):794–802

Article  CAS  PubMed  Google Scholar 

Kim BK, Kang HJ, Hong KT et al (2019) Successful preemptive therapy with single-dose rituximab for Epstein-Barr virus infection to prevent post-transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation. Transpl Infect Dis 21(6):e13182

Article  CAS  PubMed  Google Scholar 

Kimura H, Kwong YL (2019) EBV viral loads in diagnosis, monitoring, and Response Assessment. Front Oncol 9:62

Article  PubMed  PubMed Central  Google Scholar